- Home
- SLS vs PBHC Comparison
SLS vs PBHC Comparison
Compare SLS & PBHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLS
- PBHC
- Stock Information
- Founded
- SLS 2012
- PBHC 1859
- Country
- SLS United States
- PBHC United States
- Employees
- SLS N/A
- PBHC N/A
- Industry
- SLS Biotechnology: Pharmaceutical Preparations
- PBHC Major Banks
- Sector
- SLS Health Care
- PBHC Finance
- Exchange
- SLS Nasdaq
- PBHC Nasdaq
- Market Cap
- SLS 100.6M
- PBHC 108.9M
- IPO Year
- SLS N/A
- PBHC N/A
- Fundamental
- Price
- SLS $1.27
- PBHC $17.24
- Analyst Decision
- SLS
- PBHC
- Analyst Count
- SLS 0
- PBHC 0
- Target Price
- SLS N/A
- PBHC N/A
- AVG Volume (30 Days)
- SLS 4.1M
- PBHC 6.2K
- Earning Date
- SLS 03-27-2025
- PBHC 01-31-2025
- Dividend Yield
- SLS N/A
- PBHC 2.32%
- EPS Growth
- SLS N/A
- PBHC N/A
- EPS
- SLS N/A
- PBHC 0.62
- Revenue
- SLS N/A
- PBHC $40,020,000.00
- Revenue This Year
- SLS N/A
- PBHC N/A
- Revenue Next Year
- SLS N/A
- PBHC N/A
- P/E Ratio
- SLS N/A
- PBHC $27.94
- Revenue Growth
- SLS N/A
- PBHC N/A
- 52 Week Low
- SLS $0.77
- PBHC $11.41
- 52 Week High
- SLS $1.84
- PBHC $19.86
- Technical
- Relative Strength Index (RSI)
- SLS 50.97
- PBHC 55.65
- Support Level
- SLS $1.20
- PBHC $17.00
- Resistance Level
- SLS $1.37
- PBHC $17.26
- Average True Range (ATR)
- SLS 0.14
- PBHC 0.20
- MACD
- SLS -0.02
- PBHC 0.03
- Stochastic Oscillator
- SLS 10.94
- PBHC 68.29
About SLS SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
About PBHC Pathfinder Bancorp Inc. (MD)
Pathfinder Bancorp Inc is a holding company for Pathfinder Bank. The Pathfinder Bank is a commercial bank engaged in attracting deposits from the general public and investing such deposits, together with other sources of funds, in loans secured by residential real estate, commercial real estate, small business loans, and consumer loans. The bank invests a portion of its assets in debt securities issued by the United States Government and its agencies and sponsored enterprises, state and municipal obligations, corporate debt securities, mutual funds, and equity securities. The principal source of income is interest on loans and investment securities.